Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 1
2011 1
2012 1
2013 1
2015 1
2016 3
2017 4
2018 5
2019 9
2020 12
2021 4
2022 8
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. Among authors: silk aw. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
Cytokine Therapy.
Silk AW, Margolin K. Silk AW, et al. Hematol Oncol Clin North Am. 2019 Apr;33(2):261-274. doi: 10.1016/j.hoc.2018.12.004. Epub 2019 Jan 28. Hematol Oncol Clin North Am. 2019. PMID: 30832999 Review.
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
Palmeri M, Mehnert J, Silk AW, Jabbour SK, Ganesan S, Popli P, Riedlinger G, Stephenson R, de Meritens AB, Leiser A, Mayer T, Chan N, Spencer K, Girda E, Malhotra J, Chan T, Subbiah V, Groisberg R. Palmeri M, et al. Among authors: silk aw. ESMO Open. 2022 Feb;7(1):100336. doi: 10.1016/j.esmoop.2021.100336. Epub 2021 Dec 23. ESMO Open. 2022. PMID: 34953399 Free PMC article.
Cutaneous Malignancies of the Head and Neck.
In GK, Thomas JS, Silk AW. In GK, et al. Among authors: silk aw. Hematol Oncol Clin North Am. 2021 Oct;35(5):991-1008. doi: 10.1016/j.hoc.2021.05.008. Epub 2021 Jul 16. Hematol Oncol Clin North Am. 2021. PMID: 34281755 Review.
Intratumoral Approaches for the Treatment of Melanoma.
Bommareddy PK, Silk AW, Kaufman HL. Bommareddy PK, et al. Among authors: silk aw. Cancer J. 2017 Jan/Feb;23(1):40-47. doi: 10.1097/PPO.0000000000000234. Cancer J. 2017. PMID: 28114253 Review.
Interferon Lambda: Toward a Dual Role in Cancer.
Lasfar A, Zloza A, Silk AW, Lee LY, Cohen-Solal KA. Lasfar A, et al. Among authors: silk aw. J Interferon Cytokine Res. 2019 Jan;39(1):22-29. doi: 10.1089/jir.2018.0046. Epub 2018 Jul 18. J Interferon Cytokine Res. 2019. PMID: 30020822 Review.
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
Jhawar SR, Thandoni A, Bommareddy PK, Hassan S, Kohlhapp FJ, Goyal S, Schenkel JM, Silk AW, Zloza A. Jhawar SR, et al. Among authors: silk aw. Front Oncol. 2017 Sep 11;7:202. doi: 10.3389/fonc.2017.00202. eCollection 2017. Front Oncol. 2017. PMID: 28955655 Free PMC article. Review.
52 results